SSGJ-612

DRUG2 trials

Sponsors

Shenyang Sunshine Pharmaceutical Co., LTD.

Conditions

Advanced Malignant TumorsLocally Advanced (Unresectable) or Metastatic Solid Tumors

Phase 1

A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors

RecruitingNCT07032298

Shenyang Sunshine Pharmaceutical Co., LTD.Advanced Malignant Tumors

Start: 2025-07-18End: 2026-06-30Target: 30Updated: 2025-07-25

Phase 2

SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors

RecruitingNCT07646626

Shenyang Sunshine Pharmaceutical Co., LTD.Locally Advanced (Unresectable) or Metastatic Solid Tumors

Start: 2026-07-17End: 2028-10-31Target: 150Updated: 2026-07-28